SCHEMBL8308440

SCHEMBL8308440

CCCC(OS(C)(=O)=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.36
SCN2A Q99250 3/20 0.36
SCN3A Q9NY46 3/20 0.36
CYP2D6 P10635 3/20 0.36
LMNA P02545 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MTOR P42345 1/20 0.36
RAB9A P51151 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
NR3C2 P08235 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NR1I2 O75469 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP2E1 P05181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318293 0.89 NR3C2 (0.38) LMNACYP2C19NR3C2PSIP1MAPK1
SCHEMBL11515358 0.78 VDR (0.40) LMNACYP1A2CYP3A4CYP2C19NPSR1
SCHEMBL5614716 0.77 KCNN4 (0.40) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL9302722 0.76 CYP2D6 (0.61) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL8318667 0.74 NR3C2 (0.38) LMNACYP2C19NR3C2PSIP1MAPK1
SCHEMBL3959640 0.73 KCNN4 (0.38) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL7799317 0.73 KCNN4 (0.38) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL3482436 0.73 KCNN4 (0.38) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL2342432 0.73 CYP2C19 (0.44) SCN1ASCN2ASCN3ACYP2D6LMNA
SCHEMBL2342433 0.73 CYP2C19 (0.44) SCN1ASCN2ASCN3ACYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929534-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS Takeda Pharmaceutical Company Limited (JP) 1999-07-21 EP disclosed
EP-0923575-A1 CYCLIC ETHER COMPOUNDS AS SODIUM CHANNEL MODULATORS Takeda Chemical Industries, Ltd. (JP) 1999-06-23 EP disclosed
WO-1998013356-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-02 WO disclosed
WO-1998008842-A1 CYCLIC ETHER COMPOUNDS AS SODIUM CHANNEL MODULATORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-03-05 WO disclosed
EP-0179383-A2 9-Amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1986-04-30 EP disclosed